USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Market Overview ScreenersIndustriesCompanies Community Investment Grader

US Market Closed: Feb 9, 18:41 PM 2012

NYSE 8081.25 1.73 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for AUXL...

Auxilium financials and fundamentals

Companies

Sectors

Advisers

More Actions
- Equity Search
- Advanced Search
- Filter Tops
- Adviser Directory
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatility
- Import Equities

19.66

Intraday

One Month

^(0.61)

3.01%

13.59

Year To Date

25.1

19.45

Trading Day

20.38

Embed Now

Diversification Suggestion

Use Auxilium to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals

1 Month Beta vs NYSE ......... 0.27

As returns on NYSE increase, Auxilium returns are expected to increase less then the market. However, during bear market, the loss on holding Auxilium will be expected to be smaller as well

AUXL

NASDAQ

Auxilium Pharmaceuticals Inc.

http://www.auxilium.com

484-321-5900

Trade Auxilium

Run Report

Correlation

Drug Related Products

Market Capitalization 942.7M

Earnings Per Share -0.783

Today Lowest 19.45

Book Value Per Share 1.862

James E. Fickenscher

Chief Financial Officer and Princip

Jennifer Evans Stacey Esq.

VP, Gen. Counsel and Sec.

Dr. Benjamin J. Del Tito Jr.

VP of Regulatory Affairs & Pro

Adrian Adams

Chief Officer, Pres and Director

Edward F. Kessig

Sr. VP of Sales

Auxilium fundamentals

Open	20.26	P/B Ratio	10.89
Volume	334016	Sector	Healthcare
Last Close	20.27	Founded	Yes
Short Ratio	7.80	Last Traded	2/9/2012
Year High	25.10	Percent Change	3.01%
Year Low	13.59	Absolute Change	0.61
EPS	-0.783	Index Membership	Not Applicable
Employees	540	Day High	20.38
Day Low	19.45	Target Price	21.43
Current EPS	-0.783	This Year EPS	-0.60
Next Year EPS	-0.38	Current PE	Not Applicable

Auxilium Performance

Embed Financials for Auxilium Pharmaceuticals Inc.

Auxilium Profile

Auxilium Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company primarily in the United States.

IXIC		0.39 %
GSPC		0.15 %
NYA		0.02 %
AUXL		3.01 %

Live Sentiment

ROAC

NGM

Bought over 300 shares of

Rock of Ages Corporation

9 minutes ago

for 5.24

SRG

NASDAQ

Bought over 90 shares of

Snam Rete Gas

28 minutes ago

for 0.0

GOOG

NASDAQ

Bought a lot of shares of

Google Inc.

37 minutes ago

for 609.85

PEP

NYSE

Bought over 90 shares of

Pepsico Inc. Common Stock

37 minutes ago

for 66.74

DEO

NYSE

Bought over 90 shares of

Diageo plc Common Stock

38 minutes ago

for 92.66

Auxilium 30-Days Moving Rating

Macroaxis Total Score

Current 30 Days Moving Rating

Estimated Market Risk

1.4

actual daily

77 %

of total potential

Expected Return

0.26

actual daily

20 %

of total potential

Risk-Adjusted Return

0.18

actual daily

11 %

of total potential

Based on monthly moving average [ change ]

Increase Risk-Adjusted return of AUXL by adding it to a well-diversified portfolio

Diversify

Auxilium Last Intraday

(0.61) Macroaxis: -0.61 Up

3.01%

20.27,20.27,19.66,19.66,20.38,19.45,19.66

20.27

19.66

Latest headlines for Auxilium

Few days ago at www.prnewswire.com

Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global ...

Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global ... PR Newswire (press release) - 5 hours ago MALVERN, Pa., Feb. 1, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Leerink Swann 2012 Global Healthcare Conference to be held February 15-16, 2012 at the Waldorf ...

Few days ago at www.sacbee.com

Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX ...

Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX ... Sacramento Bee - 17 hours ago By Auxilium Pharmaceuticals, Inc. MALVERN, Pa., Jan. 26, 2012 -- /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the first cohort of patients has been dosed in its phase Ib ...

Few days ago at www.streetinsider.com

Auxilium (AUXL) Does First Patients in XIAFLEX Phase Ib

StreetInsider.com (subscription) - Jan 26, 2012 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), announced that the first cohort of patients has been dosed in its phase Ib trial of XIAFLEX (collagenase clostridium histolyticum) for the treatment of edematous fibrosclerotic panniculopathy (EFP), ... Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX ... - NEWS.GNOM.ES (press release)

Few days ago at www.fnno.com

Auxilium Pharmaceuticals In Retrospect: Shares Down 2.3% Since Upgraded One ...

Auxilium Pharmaceuticals In Retrospect: Shares Down 2.3% Since Upgraded One ... Financial News Network Online - 2 hours ago RBC Capital upgraded Auxilium Pharmaceuticals (NASDAQ:AUXL) from Sector Perform to Outperform a week ago. The shares closed at $19.27, or 2.3% under the $19.73 price of one week ago.

Few days ago at www.fnno.com

Auxilium Pharmaceuticals had the Lowest Relative Performance in the ...

Auxilium Pharmaceuticals had the Lowest Relative Performance in the ... Financial News Network Online - Jan 24, 2012 Here are 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were underperforming.